Protocols that make sense of dosing.

BPC-157 dosing protocol for tissue repair, gut healing, and injury recovery with multiple vial size options.

CJC-1295 without DAC (Mod GRF 1-29) dosing protocol — the short-acting GHRH analog for daily GH research.

Pinealon dosing protocol — the Khavinson bioregulator for sleep and brain health, targeting sleep quality and cognitive resilience; pairs with DSIP.

CJC-1295 (No DAC) + Ipamorelin blend protocol — the gentle GH pulse stack as a single 10 mg vial, without the appetite side effects of GHRP-2/6.

Sermorelin dosing protocol — the GHRH analog for nightly growth hormone research. Classic use is nightly SC injection to boost sleep-time GH.

The classic GH secretagogue stack — CJC-1295 (No DAC) stimulates pituitary GH release while Ipamorelin amplifies the pulse amplitude.

Ovagen dosing protocol — the Khavinson bioregulator peptide for ovarian tissue research. Microgram-level dosing makes dilution choices the whole ballgame.

Cortagen dosing protocol — the Khavinson bioregulator peptide for nervous tissue research. The brain-repair member of the Russian bioregulator family.

Epitalon (Epithalon) dosing protocol — the tetrapeptide studied for telomere and circadian research.

LL-37 dosing protocol — the cathelicidin antimicrobial peptide for immune and wound-healing research.

IGF-1 LR3 dosing protocol — the long-acting insulin-like growth factor for muscle and recovery research.

Tri-Heal blend protocol — the TB-500 + BPC-157 + KPV tendon-and-joint repair stack. Doses are total blend; KPV adds an anti-inflammatory layer.

FOXO4-DRI dosing protocol — the senolytic peptide that targets senescent 'zombie' cells and pushes them into apoptosis, with delicate microgram dosing.

Ipamorelin dosing protocol — the selective, gentle GH secretagogue favored for daily use, without the appetite or prolactin/cortisol bumps of older GHRPs.

NAD+ protocol for intramuscular and subcutaneous administration — the coenzyme central to cellular energy, DNA repair, and sirtuin activation.

ARA-290 (Cibinetide) dosing protocol — the erythropoietin-derived peptide for nerve and inflammation research.

MGF dosing protocol — mechano-growth factor for localized muscle repair. An IGF-1 splice variant released in exercised muscle, injected near the target.

KPV dosing protocol — the anti-inflammatory tripeptide for gut and tissue repair research — a three-amino-acid alpha-MSH fragment.

Cartalax dosing protocol — the bioregulator peptide for cartilage and joint research, most common in joint-repair stacks alongside BPC-157.

SLU-PP-332 dosing protocol — the ERR agonist exercise mimetic for endurance and mitochondrial research.

AICAR dosing and reconstitution protocol — the AMPK-activating research compound for metabolic and endurance protocols.

Tesamorelin dosing protocol — the FDA-approved GHRH analog studied for visceral fat reduction. The standard 2 mg daily dose is the GHRH-class heavy hitter.

Gonadorelin dosing protocol — the GnRH analog for HPTA restart and fertility research, triggering LH and FSH for testosterone and sperm production.

Selank dosing protocol — the anxiolytic nootropic peptide for mood and focus research. A synthetic tuftsin-based peptide; SC injection is the common route.

GHK-Cu copper peptide protocol for skin health, tissue repair, and anti-aging research. Covers reconstitution, syringe units, and the full dose range.

Kisspeptin dosing protocol — the upstream reproductive peptide for libido and fertility research, sitting atop the axis that drives the GnRH cascade.

Neuroxelin blend protocol — the 48 mg nootropic combination for focus and mood research. A fixed-ratio blend of cognitive peptides in a single vial.

Livagen dosing protocol — the Khavinson bioregulator peptide for liver and detox research. A short-cycle compound with a gentle dose curve.

The gold standard repair stack. Combine BPC-157 and TB-500 for enhanced healing of injuries, tendons, and post-surgery recovery.

Comprehensive dosing protocol for Retatrutide including reconstitution, titration schedule, cycle management, and safety considerations.

Adipotide dosing protocol — the pro-apoptotic peptide that targets the blood vessels feeding white fat tissue, cutting off the depot's supply line.

CJC-1295 with DAC dosing protocol — the long-acting GHRH analog for twice-weekly growth hormone research.

SS-31 (Elamipretide) dosing protocol — the mitochondrial peptide that targets cardiolipin for cellular energy research.

Cerebrolysin dosing protocol — the porcine brain peptide for neuroprotection and cognition research.

GHRP-6 dosing protocol — the classic GH secretagogue known for strong pulses and a notable appetite boost.

TB-500 (Thymosin Beta-4) dosing protocol for tissue repair and recovery acceleration. Promotes cell migration, angiogenesis, and actin binding.

Adamax dosing protocol — the Semax-derived nootropic for focus and memory research. An adamantane group boosts brain uptake for longer-lasting focus.

HCG dosing protocol — the LH analog for testicular maintenance and post-cycle recovery research, dosed in IU with HCG-specific unit math.

Semaglutide dosing protocol covering all vial sizes, titration schedule, and cycle guidelines. The GLP-1 receptor agonist for weight management research.

AOD-9604 + CJC-1295 + Ipamorelin blend protocol — the fat-loss and GH-pulse triple stack. Each unit delivers 20 mcg AOD, 10 mcg CJC, and 10 mcg Ipamorelin.

Semax dosing protocol — the ACTH-derived nootropic peptide for focus and cognition research. Developed in Russia; SC injection is the standard route.

Survodutide dosing protocol — the GLP-1/glucagon dual agonist titrated over 12+ weeks, boosting energy burn while titration manages side effects.

Melanotan II dosing protocol — the melanocortin peptide for tanning research, with strict dose discipline.

GLOW blend protocol — the famous BPC-157 + TB-500 + GHK-Cu skin and recovery stack in a single 70 mg vial. One shot replaces three pins.

Oxytocin dosing protocol — the bonding peptide for social, mood, and intimacy research. SC injection is the standard route for reliable absorption.

Prostamax dosing protocol — the bioregulator peptide for prostate tissue research. A short-cycle maintenance compound rather than a rapid-response peptide.

Complete dosing protocol for Tirzepatide with dual GLP-1/GIP agonism, reconstitution steps, and titration schedule.

Tesamorelin + Ipamorelin blend protocol — the fat-loss-meets-GH-pulse stack in one vial, pairing the GHRH analog with the selective secretagogue.

PE-22-28 (Spadin) dosing protocol — the TREK-1 channel peptide for mood research, blocking the same target as experimental antidepressants.

Vilon dosing protocol — the Khavinson bioregulator peptide for immune system research. A short-cycle compound — a handful of days at a time.

PNC-27 dosing protocol — the p53-derived membranolytic peptide for cancer research. Combines a p53 fragment with a membrane-penetrating domain.

CJC-1295 + GHRP-2 blend protocol — the classic GH secretagogue stack in a 10 mg vial. GHRH analog plus ghrelin-mimetic for a stronger, broader GH pulse.

PEG-MGF dosing protocol — the pegylated MGF with a longer half-life for muscle repair research. Same satellite-cell mechanism as MGF, dosed less often.

Snap-8 topical protocol — the anti-wrinkle peptide for cosmetic research, mixed into a base cream. Inhibits SNARE-complex formation like Argireline.

Injectable L-Carnitine dosing protocol — the fat-transport amino acid for metabolic research. Injection bypasses carnitine's poor oral bioavailability.

Chonluten dosing protocol — the Khavinson bioregulator peptide for lung and respiratory research. The dose curve runs 250 mcg to 4 mg.

Vesugen dosing protocol — the Khavinson bioregulator peptide for vascular and endothelial research, part of the Russian peptide family.

AOD-9604 fat loss peptide protocol — the HGH 177-191 fragment that stimulates lipolysis without affecting blood sugar.

HGH 191AA dosing protocol — recombinant human growth hormone titrated from 200 to 900 mcg daily, with IU-to-mg math and a weekly ramp schedule.

KLOW blend protocol — the GLOW stack plus KPV for gut-and-skin repair. BPC-157, TB-500, KPV, and GHK-Cu share an 80 mg vial with per-unit delivery math.

5-Amino-1MQ dosing protocol — the NMNAT2 activator for NAD metabolism and metabolic health research.

Cagrilintide dosing protocol — the long-acting amylin analog for appetite and weight-loss research, often paired with a GLP-1 like semaglutide.

Glutathione dosing protocol — the body's master antioxidant for detox and cellular defense. Oral barely absorbs — the injectable form moves the needle.

Thymosin Alpha-1 dosing protocol — the thymus-derived peptide for immune research. Modulates T-cell function; approved for hepatitis B and C.

Testagen dosing protocol — the Khavinson bioregulator peptide for testicular tissue research. Targets Leydig cells; a soft approach to endocrine support.

DSIP dosing protocol — the delta sleep-inducing peptide for deep sleep and recovery research. Not a sedative: it supports slow-wave sleep architecture.

CagriSema blend protocol — the fixed-ratio Cagrilintide + Semaglutide combination behind headline clinical weight-loss results.

Mazdutide dosing protocol — the dual GLP-1/glucagon agonist for weight-loss research. The glucagon arm adds energy expenditure to GLP-1 suppression.

MOTS-c mitochondrial peptide protocol for energy, metabolic health, and anti-aging research. Covers reconstitution, syringe units, and dosing for this MDP.

PT-141 (Bremelanotide) dosing protocol — the melanocortin peptide for sexual-health research. Drives arousal centrally; on-demand dose is 1.75 mg SC.

HMG dosing protocol — the FSH/LH gonadotropin for fertility research. FSH drives sperm, LH drives testosterone; the HCG companion in HPTA restart.

GHRP-2 dosing protocol — the growth hormone secretagogue for daily pulse research. Binds the ghrelin receptor; often stacked with CJC-1295 or Sermorelin.